Administration of IL-33 enhances allodynia in chronic constriction injury (CCI) mice whereas neutralizing IL-33 ameliorates hyperalgesia in arthritis, which suggests that IL-33 has a potential to contributes to pain status [14]. The gene discussed is IL33; the disease is arthritic joint disease.